TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
63.38
+3.55 (5.93%)
At close: Nov 9, 2026, 4:00 PM EST
63.04
-0.34 (-0.54%)
Pre-market: Nov 10, 2026, 7:08 AM EST
TG Therapeutics Market Cap
TG Therapeutics has a market cap or net worth of $8.99 billion as of November 9, 2026. It is the 2,321st most valuable company in the world and the 821st biggest in the United States. Its market cap has increased by 66.36% in one year.
Market Cap
8.99B
Enterprise Value
9.19B
1-Year Change
66.36%
Global Rank
Country Rank
#821 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, TG Therapeutics's market cap has increased from $34.90M to $8.99B, an increase of 25,660.27%. That is a compound annual growth rate of 21.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 9.16B | 93.50% |
| Dec 31, 2025 | 4.73B | 1.01% |
| Dec 31, 2024 | 4.69B | 81.18% |
| Dec 29, 2023 | 2.59B | 50.41% |
| Dec 30, 2022 | 1.72B | -36.69% |
| Dec 31, 2021 | 2.72B | -60.29% |
| Dec 31, 2020 | 6.84B | 518.96% |
| Dec 31, 2019 | 1.11B | 225.13% |
| Dec 31, 2018 | 339.90M | -41.33% |
| Dec 29, 2017 | 579.30M | 127.62% |
| Dec 30, 2016 | 254.50M | -59.38% |
| Dec 31, 2015 | 626.60M | -10.02% |
| Dec 31, 2014 | 696.40M | 433.23% |
| Dec 31, 2013 | 130.60M | 43.20% |
| Dec 31, 2012 | 91.20M | 91,100.00% |
| Dec 30, 2011 | 100.00K | -95.45% |
| Dec 31, 2010 | 2.20M | -58.49% |
| Dec 31, 2009 | 5.30M | 783.33% |
| Dec 31, 2008 | 600.00K | -90.63% |
| Dec 31, 2007 | 6.40M | -86.18% |
| Dec 29, 2006 | 46.30M | -38.35% |
| Dec 30, 2005 | 75.10M | 181.27% |
| Dec 31, 2004 | 26.70M | -27.64% |
| Dec 31, 2003 | 36.90M | 623.53% |
| Dec 31, 2002 | 5.10M | -49.50% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Madrigal Pharmaceuticals | 9.28B |
| ImmunityBio | 9.15B |
| Krystal Biotech | 8.92B |
| Protagonist Therapeutics | 8.54B |
| Arrowhead Pharmaceuticals | 8.22B |
| Corcept Therapeutics | 7.96B |
| Rhythm Pharmaceuticals | 7.78B |
| Praxis Precision Medicines | 7.75B |